• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Sale!
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The World Market for Personalized Medicine Tests for Cancer

$2,396.00 – $4,800.00

Clear
SKU: KLI15230306 Category: Diagnostics Market Research Pages: 140
  • Description
  • Table of Contents
  • Latest reports

Description

The World Market for Personalized Medicine Tests for Cancer

This report, Personalized Medicine Tests for Cancer, provides an authoritative look at the market for companion and personalized medicine testing for cancer. The report includes a market size and forecast for personalized medicine testing by geography (US, EU, ROW). Company profiles are included and products are identified by status (on the market, in development)

Table of Contents

Chapter One: Executive Summary

The Scourge of Cancer

Definitions of Companion Diagnostics and Cancer Diagnostics

Types of Tests Included

Marketing Personalized Medicine-Based Cancer Tests

Market

Point of View

Chapter Two: Introduction

Cancer Treatments

Cancer Risk Assessment

Cancer Screening

Cancer Monitoring

Prognosis Assessment

Technologies Used

Immunoassays:

Immunohistochemistry (IHC):

Flow Cytometry:

In Situ Hybridization:

Nucleic Acid Amplification Technologies:

Analysis of Gene Expression Patterns (Gene Signatures):

Microarrays:

Sequencing Technologies:

Mass Spectrometry:

Liquid Biopsies:

Information Technology:

Test Targets

HER2 Overexspression

EGFR

KRAS Mutations

BRAF Mutations

UGT1A1 Genetic Variants

5-Flurouracil Therapy

PIK3CA Mutations

KIF6 Mutations

ALK Mutations

Chapter Three: Market Analysis

Products on the Market

Market Analysis

Drivers

Diagnostic Companies and Pharmaceutical Companies

Growth by Geography

Chapter Four: Company Profiles.

20/20 GeneSystems, Inc.

Company Overview

Products

Abbott Laboratories

Company Overview

Products

ACT Genomics Co., Ltd.

Products

Adaptive Biotechnologies Corporation

Company Overview

Products

Admera Health (A GENEWIZ Company)

Company Overview

Agena Bioscience Inc.

Company Overview

Products

Agendia NV

Company Overview

Amoy Diagnostics Co., Ltd.

Company Overview

Products

ARKRAY, Inc.

Company Overview

Products

Biocartis

Company Overview

Products

Pharmaceutical Company Agreements

bioMérieux SA

Company Overview

Products

Cepheid (Danaher)

Company Overview

Products

Genomic Health, Inc.

Company Overview

Products

Genoptix (A Novartis Company)

Company Overview

Luminex Corporation

Company Overview

Products

Myriad Genetics, Inc.

Company Overview

Products

Qiagen N.V.

Company Overview

Products

QuanDx Inc.

Company Overview

Quest Diagnostics

Company Overview

Products

Qvella Corporation

RiboMed Biotechnologies, Inc.

Company Overview

Products

Roche

Company Overview

Products

Siemens Healthcare

Company Overview

Products

Symbiodx

Company Overview

Products

Theranostics Health Inc. (Acquired by Avant Diagnostics, Inc.)

Overview

Products

Thermo Fisher Scientific, Inc.

Company Overview

Products

LIST OF EXHIBITS

Figure 1-1: Cancer Cases by Type

Figure 1-2: Tests by Biomarker Type

Figure 1-3 Tests by Status

Figure 1-4 Market for Personalized Medicine Cancer Tests

Table 2-1 Cancer Biomarkers

Table 3-1 Personalized Medicine Cancer Tests on the Market

Table 3-2 The Market for Personalized Cancer Tests by Geographic Region

Figure 3-3 The Market for Personalized Cancer Tests by Geographic Region

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Molecular Imaging Agents and Systems – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Mergers and Acquisitions in the IVD MarketUrgent Care Market (Clinic Growth, Revenues by Procedure, IVD and Vaccine S...
Scroll to top